Innate Pharma
Tracked across 3 events · 19 articles · First seen Apr 02, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Innate Pharma filed its 2025 Universal Registration Document and Form 20-F annual report, fulfilling regulatory obligations for publicly traded companies.
Apr 02, 2026 · 7 articles
Business
Impact: Innate Pharma will present its oncology pipeline and strategies at the AACR Oncology Industry Partnering Event, providing an opportunity to attract investors and accelerate therapy development.
Apr 08, 2026 · 6 articles
Regulatory
Impact: Innate Pharma released its total number of shares outstanding and voting rights as of April 9, 2026, in compliance with French regulatory requirements.
Apr 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Innate Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard